Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx

NCT: NCT04028674 · ACTIVE_NOT_RECRUITING

NCT IDNCT04028674
StatusACTIVE_NOT_RECRUITING
Start Date2021-01-14
Completion2028-12
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

Brief Summary

The primary purpose of this project is to evaluate the safety of new treatment termed bilateral laryngeal pacing to improve treatment outcomes in patients with bilateral vocal fold paralysis (BVFP) (Aim 1). Outcome measures related to voice and ventilation will also provide initial insights into the efficacy of bilateral (Aim 2) and unilateral (Aim 3) stimulation of the implanted device to improve treatment outcomes in patients with BVFP.

Frequently Asked Questions

What is Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx?

Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx is a clinical trial registered under NCT04028674. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04028674?

The current status of NCT04028674 (Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx) is: ACTIVE_NOT_RECRUITING.

When did Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx start?

Functional Electrical Stimulation of the Bilaterally Paralyzed Human Larynx started on 2021-01-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑